Cerity Partners LLC Purchases 36,181 Shares of Relx Plc (NYSE:RELX)

Cerity Partners LLC lifted its position in shares of Relx Plc (NYSE:RELX - Free Report) by 33.5% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 144,255 shares of the technology company's stock after purchasing an additional 36,181 shares during the period. Cerity Partners LLC's holdings in Relx were worth $7,272,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of RELX. DRW Securities LLC boosted its stake in shares of Relx by 5.9% during the 4th quarter. DRW Securities LLC now owns 4,652 shares of the technology company's stock valued at $211,000 after purchasing an additional 259 shares in the last quarter. Kovitz Investment Group Partners LLC lifted its holdings in Relx by 3.4% in the fourth quarter. Kovitz Investment Group Partners LLC now owns 8,159 shares of the technology company's stock worth $371,000 after buying an additional 267 shares during the period. Ascent Group LLC boosted its position in Relx by 2.0% during the 4th quarter. Ascent Group LLC now owns 14,024 shares of the technology company's stock valued at $637,000 after acquiring an additional 277 shares in the last quarter. Portside Wealth Group LLC grew its holdings in shares of Relx by 2.5% during the 1st quarter. Portside Wealth Group LLC now owns 11,710 shares of the technology company's stock worth $590,000 after acquiring an additional 283 shares during the period. Finally, Golden State Wealth Management LLC raised its position in shares of Relx by 100.0% in the 1st quarter. Golden State Wealth Management LLC now owns 588 shares of the technology company's stock worth $30,000 after acquiring an additional 294 shares in the last quarter. 15.02% of the stock is owned by institutional investors.

Relx Stock Up 1.1%

Shares of RELX traded up $0.58 during mid-day trading on Wednesday, reaching $53.76. The company had a trading volume of 1,934,523 shares, compared to its average volume of 755,631. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. The company has a market capitalization of $98.74 billion, a price-to-earnings ratio of 28.90, a price-to-earnings-growth ratio of 3.25 and a beta of 0.83. The firm has a 50-day moving average price of $53.71 and a 200 day moving average price of $50.97. Relx Plc has a 52 week low of $43.45 and a 52 week high of $56.33.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Wall Street Zen lowered Relx from a "buy" rating to a "hold" rating in a research report on Saturday. The Goldman Sachs Group assumed coverage on shares of Relx in a report on Wednesday, March 26th. They set a "buy" rating on the stock. Finally, Morgan Stanley reiterated an "overweight" rating on shares of Relx in a research note on Wednesday, April 16th. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Buy".

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.